Prosight Management, LP

Position in COYA — Coya Therapeutics, Inc.

CIK 1617201 DALLAS, TX

Position in COYA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$994,500

-$661,718 QoQ

Shares Held

170,000

-59.6% QoQ

Ownership

0.725%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#10

of 54 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Prosight Management, LP holds $415,390,745 across 22 Biotechnology names. COYA ranks #21 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LKFT	Lakefront Biotherapeutics NV	2,043,344	$61,259,453
2	JANX	Janux Therapeutics, Inc.	3,804,481	$58,436,828
3	NKTR	Nektar Therapeutics	810,000	$56,546,100
4	STTK	Shattuck Labs, Inc.	5,957,877	$41,347,666
5	INSM	INSMED Inc	375,609	$40,047,431
6	ALNY	Alnylam Pharmaceuticals, Inc.	98,080	$29,525,022
7	SNDX	Syndax Pharmaceuticals Inc	1,200,000	$26,232,000
8	KURA	Kura Oncology, Inc.	2,021,964	$22,180,945

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$994,500	170,000	-59.6%	Shares	Sole	2026-08-14
2026-03-31	$1,656,218	420,360	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.